Keyphrases
5-year Outcomes
29%
Acute Coronary Syndrome
7%
Adverse Cardiac Events
37%
Adverse Outcomes
29%
All-cause Mortality
7%
All-comers
13%
Angina Pectoris
11%
Annual Events
14%
Cardiac Death
20%
Cipher
29%
Clinical Outcomes
64%
Confidence Interval
14%
Continuous Surveillance
7%
Coronary Artery Segment
7%
Coronary Stent
35%
Coronary Stent Implantation
29%
Drug-eluting Coronary Stent
14%
Drug-eluting Stent
32%
Drug-eluting Stent Implantation
29%
Event Rate
27%
First Year
14%
First-generation Drug-eluting Stent
6%
Hazard Ratio
44%
In-stent Restenosis
7%
Left Anterior Descending Artery
29%
Left Main Coronary Artery
32%
Medical Attention
14%
Multivariate Analysis
6%
Myocardial Infarction
16%
Odds Ratio
9%
Paclitaxel
58%
Paclitaxel-eluting Stent
7%
Patients Included
7%
Predictive Score
13%
Randomized Trial
14%
Sirolimus
58%
Sirolimus-eluting Stent
7%
ST-elevation Myocardial Infarction (STEMI)
41%
Stent
38%
Stent Diameter
29%
Stent Length
6%
Stent Thrombosis
73%
Stent Treatment
19%
Stent Type
14%
Target Lesion Failure
9%
Target Lesion Revascularization
6%
Target Vessel Revascularization
16%
Taxus
29%
Treatment Failure
19%
Unselected Patients
13%
Medicine and Dentistry
Acute Coronary Syndrome
7%
Adverse Event
14%
Adverse Outcome
29%
All Cause Mortality
7%
Artery
29%
Call Rate
7%
Coronary Artery
7%
Drug-Eluting Stent
58%
Epileptic Absence
7%
Hazard Ratio
44%
Heart Death
29%
In-Stent Restenosis
7%
Major Adverse Cardiac Event
55%
Multivariate Analysis
6%
Myocardial Infarction
25%
Non ST Segment Elevation Myocardial Infarction
17%
Odds Ratio
9%
Paclitaxel
58%
Percutaneous Coronary Intervention
13%
Rapamycin
58%
ST Segment Elevation Myocardial Infarction
44%
Stable Angina Pectoris
17%
Stent Thrombosis
91%
Target Lesion
9%
Target Lesion Revascularization
6%
Target Vessel Revascularization
25%
Unstable Angina Pectoris
17%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
7%
Acute Heart Infarction
14%
Adverse Event
5%
Adverse Outcome
29%
All Cause Mortality
29%
Coronary Artery Obstruction
14%
Epileptic Absence
7%
Heart Death
57%
Heart Infarction
42%
In-Stent Restenosis
7%
Major Adverse Cardiac Event
48%
Non ST Segment Elevation Myocardial Infarction
9%
Paclitaxel
58%
Rapamycin
58%
Restenosis
29%
ST Segment Elevation Myocardial Infarction
35%
Stable Angina Pectoris
9%
Stent Thrombosis
100%
Taxus
29%
Unstable Angina Pectoris
9%